Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

6.58
+0.11001.70%
Post-market: 6.620.0400+0.61%19:59 EST
Volume:22.84M
Turnover:148.39M
Market Cap:2.65B
PE:-3.89
High:6.72
Open:6.61
Low:6.31
Close:6.47
Loading ...

BUZZ-Nvidia-backed Recursion Pharmaceuticals falls on bigger-than-expected Q4 loss

Reuters
·
28 Feb

Recursion Pharmaceuticals Shares Slide 10% After Bigger-Than-Expected Q4 Loss

THOMSON REUTERS
·
28 Feb

Recursion Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Recursion Pharmaceuticals Shares Slide 12.3% Premarket After Bigger-Than-Expected Q4 Loss

THOMSON REUTERS
·
28 Feb

Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
28 Feb

Recursion Pharmaceuticals: Files for Offering of up to $500 Mln Class a Common Stock - SEC Filing

THOMSON REUTERS
·
28 Feb

Recursion Pharmaceuticals Q4 Loss Widens, Revenue Declines

MT Newswires Live
·
28 Feb

Recursion Pharmaceuticals Q4 EPS $(0.53) Misses $(0.46) Estimate, Sales $4.55M Miss $19.04M Estimate

Benzinga
·
28 Feb

Recursion Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance
·
28 Feb

Stock Track | Recursion Pharmaceuticals Plunges 5.87% Pre-Market After Q4 Revenue Miss Despite Pipeline Progress

Stock Track
·
28 Feb

Recursion Pharmaceuticals reports Q4 EPS (53c) vs. (42c) last year

TIPRANKS
·
28 Feb

Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q4 Net Loss of $0.53 a Share, vs. FactSet Est of $0.38 Loss

MT Newswires Live
·
28 Feb

Recursion Pharmaceuticals Inc Q4 Shr View $-0.43 -- Lseg Ibes Data

THOMSON REUTERS
·
28 Feb

Press Release: Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Dow Jones
·
28 Feb

Recursion Pharmaceuticals Inc expected to post a loss of 43 cents a share - Earnings Preview

Reuters
·
26 Feb

Recursion Pharmaceuticals put volume heavy and directionally bearish

TIPRANKS
·
25 Feb